Programs & Services
Specialties & Conditions
My goal is to contribute to the understanding of the pathogenesis of Idiopathic Pulmonary Fibrosis and autoimmune lung disease via basic, translational, and clinical research with the ultimate aim to improve quality of life for patients with pulmonary fibrosis. I have a strong interest in autoimmune lung disease and the intersection between innate immunity and the development of fibrotic lung disease.
||Weill Medical College of Cornell University, New York, NY, MD
||Emory University School of Medicine, Atlanta, GA, Chief Resident
||Emory University School of Medicine, Atlanta, GA,
||University of Colorado Denver School of Medicine, Research Fellowship
||University of Colorado Denver School of Medicine,
Awards & Recognition
2011: American Thoracic Society Travel Award, American Thoracic Society
2006: Chief Resident, Emory School of Medicine
2006: Ambulatory Clinic Physician Award- Awarded for outstanding ambulatory clinical care, professionalism, conference attendance and participation, Emory University School of Medicine
2003: Alfred Moritz Michaelis Prize in Medicine- Awarded for "general efficiency" in Medicine, Weill Medical College of Cornell University
1998: Graduation with distinction in all subjects, Cornell University
1997: Golden Key International Honor Society, Cornell University
1994-1998: Isabel Peard Cornell Tradition Fellow, Cornell University
1994-1998: Mening Family Cornell National Scholar, Cornell University
2010: Internal Medicine-Critical Care Medicine
2009: Internal Medicine-Pulmonary Disease
2007: Internal Medicine
American Thoracic Society
American College of Chest Physicians
Redente EF, Jacobsen KM, Solomon JJ, Lara AR, Faubel S, et al. Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis. American journal of physiology. Lung cellular and molecular physiology. 2011; 301(4):L510-8.PMID:21743030. PMCID: PMC3191751.
Keith RC, Powers JL, Redente EF, Sergew A, Martin RJ, et al.A novel model of rheumatoid arthritis-associated interstitial lung disease in SKG mice.Experimental lung research. 2012; 38(2):55-66.PMID:22185348.
Keith RC, Sokolove J, Edelman BL, Lahey L, Redente EF, et al. Testosterone is protective in the sexually dimorphic development of arthritis and lung disease in SKG mice. Arthritis and rheumatism. 2013; 65(6):1487-93. NIHMSID: NIHMS457088. PMID:23529475. PMCID:PMC3672393.
Roy MG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, et al. Muc5b is required for airway defence.Nature. 2014; 505(7483):412-6. NIHMSID: NIHMS571052. PMID:24317696. PMCID:PMC4001806.
Redente EF, Keith RC, Janssen W, Henson PM, Ortiz LA, et al.Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.American journal of respiratory cell and molecular biology. 2014; 50(4):825-37. PMID:24325577. PMCID:PMC4068926.
Full faculty appointment, University of Colorado Denver
Teaching & Professional Positions
Assistant Professor, VA Eastern Colorado Health Care System
Conflicts of Interest
National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice
and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management
plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians
or scientists. View this faculty member’s industry relationships and collaborations.
The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes.
Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey